Founded in 2004, Elite Research Institute is a leading provider of independent clinical trials. We specialize in conducting clinically and operationally complex studies with unsurpassed data integrity. In our relentless pursuit of excellence, Elite Research Institute partners with biopharmaceutical and pharmaceutical companies to achieve medical and scientific advances with the capacity to impact the quality of life for millions of people. As a provider of the highest quality Phase I–IV clinical trials in the industry, Elite has performed hundreds of clinical trials on more than 10,000 patients. Elite routinely performs the most challenging studies in the field, including first-in-human, first-in-patient, maximum tolerated dose, proof-of-concept, drug interactions, and special population trials. To date, Elite has met 99 percent of its enrollment goals with a 95 percent subject retention rate. Mission Statement Elite Research Institute is a Phase I-IV organization committed to providing our sponsors with rapid study enrolment, quality data and robust study conduct in order to lessen the time and expense of bringing new therapies to patients in need. We pledge to provide “best in class” service, with total commitment to subject safety, ethics, privacy, respect and quality performance standards. Current Trials - Herpes Zoster (Shingles) - Alzheimer Disease - Rheumatoid Arthritis (RA) - Diabetes Type II with Kidney Disease - Healthy Elderly Subjects - Acute Hip Fracture